Structural Basis of Substrate Recognition and Covalent Inhibition of Cdu1 from Chlamydia trachomatis
| Autor: | Thomas B. Adler, Alexander V. Statsyuk, Theresa Klemm, Stefan G. Kathman, Yesid A. Ramirez, Christoph A. Sotriffer, Eva Altmann, Caroline Kisker, Florian Sauer, Christian Tiesmeyer |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Adenain Stereochemistry medicine.medical_treatment Chlamydia trachomatis Saccharomyces cerevisiae medicine.disease_cause Biochemistry Article Substrate Specificity Fungal Proteins 03 medical and health sciences Ubiquitin Catalytic Domain Drug Discovery Hydrolase medicine Humans Amino Acid Sequence General Pharmacology Toxicology and Pharmaceutics Enzyme Inhibitors Pharmacology chemistry.chemical_classification Protease 030102 biochemistry & molecular biology biology Deubiquitinating Enzymes Organic Chemistry Molecular Docking Simulation Cysteine Endopeptidases 030104 developmental biology Enzyme Pyrimidines chemistry Docking (molecular) Covalent bond biology.protein Molecular Medicine Oligopeptides Sequence Alignment |
| Zdroj: | ChemMedChem. 13(19) |
| ISSN: | 1860-7187 |
| Popis: | Based on the similarity between the active sites of the deubiquitylating and deneddylating enzyme ChlaDub1 (Cdu1) and the evolutionary related protease adenain a target-hopping approach screening on a focused set of adenain inhibitors has been pursued. The thereby identified cyano-pyrimidine based inhibitors represent the first active-site directed small molecule inhibitors for Cdu1. High-resolution crystal structures of Cdu1 in complex with two covalently bound cyano-pyrimidines as well as with its substrate ubiquitin have been obtained. These structural data were complemented by enzymatic assays and covalent docking studies to provide insight into Cdu1s substrate recognition, active site pocket flexibility and potential hotspots for ligand interaction. Combined, these data provide a strong foundation for future structure-guided medicinal chemistry optimization of this cyano-pyrimidine based scaffold towards more potent and specific Cdu1 inhibitors. [Image: see text] Covalent death sentence: Bacterial deubiquitylating enzymes (DUBs) can be utilized to enhance their pathogenicity. In our study, we have successfully harnessed the structural similarities of the active site of the chlamydial deubiquitylase 1 (Cdu1) with an evolutionarily related protease to discover the very first active-site covalent Cdu1 inhibitors. We demonstrate the molecular basis of Cdu1 ubiquitin recognition and establish criteria for the structure-informed medicinal chemistry optimization of potential Cdu1 specific inhibitors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text